| Lisa A Turri, MD FACOG | |
|
2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 | |
| (516) 678-4000 | |
| (516) 678-9573 |
| Full Name | Lisa A Turri |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 2000 N Village Ave, Rockville Centre, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922053024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 202546 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center | Rockville centre, NY | Hospital |
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
American consumers are being warned by the Food and Drug Administration (FDA) about the dangers of a product which promises to increase eyelash growth.
The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.
AIDS-related mortality rates in Mexico have remained somewhat steady over the past 12 years, despite increased access to antiretroviral drugs in the country, officials at the National Institute of Public Health, or INSP, said recently, The News/Individual.com reports.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."
› Verified 5 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
American consumers are being warned by the Food and Drug Administration (FDA) about the dangers of a product which promises to increase eyelash growth.
The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.
AIDS-related mortality rates in Mexico have remained somewhat steady over the past 12 years, despite increased access to antiretroviral drugs in the country, officials at the National Institute of Public Health, or INSP, said recently, The News/Individual.com reports.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."
› Verified 5 days ago
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
American consumers are being warned by the Food and Drug Administration (FDA) about the dangers of a product which promises to increase eyelash growth.
The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.
AIDS-related mortality rates in Mexico have remained somewhat steady over the past 12 years, despite increased access to antiretroviral drugs in the country, officials at the National Institute of Public Health, or INSP, said recently, The News/Individual.com reports.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa A Turri, MD FACOG 2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 Ph: (516) 678-4000 | Lisa A Turri, MD FACOG 2000 N Village Ave, Suite 109, Rockville Centre, NY 11570-1078 Ph: (516) 678-4000 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
American consumers are being warned by the Food and Drug Administration (FDA) about the dangers of a product which promises to increase eyelash growth.
The U.S. Food and Drug Administration today approved a potentially groundbreaking new drug to treat women with advanced breast cancer, signaling a new treatment strategy to arrest tumor growth and extend the time before the cancer worsens.
AIDS-related mortality rates in Mexico have remained somewhat steady over the past 12 years, despite increased access to antiretroviral drugs in the country, officials at the National Institute of Public Health, or INSP, said recently, The News/Individual.com reports.
Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."
› Verified 5 days ago
Dr. Francine Amelia Guzman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 104, Rockville Centre, NY 11570 Phone: 516-678-4222 Fax: 516-678-0919 | |
Carolyn Oh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 371 Merrick Rd, Suite 203, Rockville Centre, NY 11570 Phone: 516-766-7626 Fax: 516-766-0744 | |
Peter Sticco, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Village Ave Ste 204, Rockville Centre, NY 11570 Phone: 516-705-2206 | |
Dr. Joan Haselkorn-lomasky, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 556 Merrick Rd, Suite 200, Rockville Centre, NY 11570 Phone: 516-255-2044 Fax: 516-255-2045 | |
Nicholas J Tarricone, MD, MHA, FACOG Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 109, Rockville Centre, NY 11570 Phone: 516-678-4000 Fax: 516-678-9573 | |
Neal H Bellin, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2000 N Village Ave, Suite 103, Rockville Centre, NY 11570 Phone: 516-684-9100 Fax: 516-764-2051 | |
Dr. Jonathan Yaakov Rosner, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8 N Oceanside Rd, Rockville Centre, NY 11570 Phone: 516-632-4636 Fax: 516-992-0802 |